Ontogeny of β-adrenoceptor/adenylyl cyclase desensitization mechanisms: The role of neonatal innervation

Brain Research

Volumn 742, Issue 1-2, 1996, Pages 317-328

  Slotkin, T A ^a   Saleh, J L ^a   Zhang, J ^a   Seidler, F J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; FLUORIDE; FORSKOLIN; ISOPRENALINE; OXIDOPAMINE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEVELOPMENT; FEMALE; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ADENYLATE CYCLASE; ANIMALS; ANIMALS, NEWBORN; FEMALE; HEART; ISOPROTERENOL; OXIDOPAMINE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA;

EID: 0030566705     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)00978-X     Document Type: Article

References (54)

1. Boreus L.O., Hjemdahl P., Lagercrantz H., Martinsson A., Yao A.C. β-Adrenoceptor function in white blood cells from newborn infants: no relation to plasma catecholamine levels. Pediatr. Res. 20:1986;1152-1155.
2. Chaudhry A., Granneman J.G. Developmental changes in adenylyl cyclase and GTP binding proteins in brown fat. Am. J. Physiol. 261:1991;R403-R411.
3. sα activity. Am. J. Physiol. 263:1992;R34-R38.
4. 3-adrenergic receptors to brown fat adenylyl cyclase. J. Pharmacol. Exp. Ther. 261:1992;633-637.
5. Chaudhry A., Muffler L.A., Yao R.H., Granneman J.G. Perinatal expression of adenylyl cyclase subtypes in rat brown adipose tissue. Am. J. Physiol. - Reg. Integr. Comp. Physiol. 39:1996;R755-R760.
6. Clark R.B., Friedman J., Dixon R.A., Strader C.D. Identification of a specific site required for rapid heterologous desensitization of the β-adrenergic receptor by cAMP-dependent protein kinase. Mol. Pharmacol. 36:1989;343-348.
7. Cros G.H., Chanez P.O., Michel A., Boucard M., Serrano J.-J. Post-natal evolution of rat cardiac β-adrenoceptors. Life Sci. 43:1988;699-706.
8. Deskin R., Seidler F.J., Whitmore W.L., Slotkin T.A. Development of α-noradrenergic and dopaminergic receptor systems depends on maturation of their presynaptic nerve terminals in the rat brain. J. Neurochem. 36:1981;1683-1690.
9. Friedhoff A.J., Miller J.C. Prenatal psychotropic drug exposure and the development of central dopaminergic and cholinergic neurotransmitter systems. Monogr. Neural Sci. 9:1983;91-98.
10. Giannuzzi C.E., Seidler F.J., Slotkin T.A. β-Adrenoceptor control of cardiac adenylyl cyclase during development: agonist pretreatment in the neonate uniquely causes heterologous sensitization, not desensitization. Brain Res. 694:1995;271-278.
11. Habib D.M., Padbury J.F., Martinez A.M., Chappell B.A., Thio S.L., Burnell E.E. Neonatal adaptation: cardiac adrenergic effector mechanisms after birth in newborn sheep. Pediatr. Res. 29:1991;98-103.
12. Hou Q.-C., Seidler F.J., Slotkin T.A. Development of the linkage of β-adrenergic receptors to cardiac hypertrophy and heart rate control: neonatal sympathectomy with 6-hydroxydopamine. J. Dev. Physiol. 11:1989;305-311.
13. Huff R.A., Seidler F.J., Slotkin T.A. Glucocorticoids regulate the ontogenetic transition of adrenergic receptor subtypes in rat liver. Life Sci. 48:1991;1059-1066.
14. Johnson G.L., Wolfe B.B., Harden T.K., Molinoff P.B., Perkins J.P. Role of β-adrenergic receptors in catecholamine-induced desensitization of adenylate cyclase in human astrocytoma cells. J. Biol. Chem. 253:1978;1472-1480.
15. Kudlacz E.M., Navarro H.A., Kavlock R.J., Slotkin T.A. Regulation of postnatal β-adrenergic receptor/adenylate cyclase development by prenatal agonist stimulation and steroids: alterations in rat kidney and lung after exposure to terbutaline or dexamethasone. J. Dev. Physiol. 14:1990;273-281.
16. Kudlacz E.M., Navarro H.A., Slotkin T.A. Phosphatidic acid phosphatase in neonatal rat lung: effects of prenatal dexamethasone or terbutaline treatment on basal activity and on responsiveness to β-adrenergic stimulation. J. Pharmacol. Exp. Ther. 250:1989;236-240.
17. Kudlacz E.M., Slotkin T.A. Regulation of neonatal rat lung compliance by β-adrenergic receptor stimulation: effects of prenatal exposure to terbutaline or dexamethasone. J. Dev. Physiol. 14:1990;307-310.
18. Lagercrantz H., Slotkin T.A. The `stress' of being born. Sci. Am. 254((April)):1986;100-107.
19. Lau C., Burke S.P., Slotkin T.A. Maturation of sympathetic neurotransmission in the rat heart. IX. Development of transsynaptic regulation of cardiac adrenergic sensitivity. J. Pharmacol. Exp. Ther. 223:1982;675-680.
20. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-270.
21. Maier J.A., Roberts J.M., Jacobs M.M. Ontogeny of fetal adenylate cyclase; mechanisms for regulation of β-adrenergic receptors. J. Dev. Physiol. 12:1989;249-261.
22. 1- and β-adrenergic receptors. Biochem. Pharmacol. 36:1987;1-6.
23. McMillian M.K., Schanberg S.M., Kuhn C.M. Ontogeny of rat hepatic adrenoceptors. J. Pharmacol. Exp. Ther. 227:1983;181-186.
24. 2+. Pharmacol. Rev. 40:1988;87-119.
25. Minneman K.P., Pittman R.N., Molinoff P.B. β-Adrenergic receptor subtypes: properties, distribution, and regulation. Ann. Rev. Neurosci. 4:1981;419-461.
26. 2 adrenergic receptors. J. Biol. Chem. 258:1983;5103-5109.
27. Navarro H.A., Kudlacz E.M., Kavlock R.J., Slotkin T.A. Prenatal terbutaline treatment: tissue-selective dissociation of perinatal changes in β-adrenergic receptor binding from regulation of adenylate cyclase activity. Life Sci. 48:1991;269-274.
28. Navarro H.A., Kudlacz E.M., Slotkin T.A. Control of adenylate cyclase activity in developing rat heart and liver: effects of prenatal exposure to terbutaline or dexamethasone. Biol. Neonate. 60:1991;127-136.
29. Ping P.P., Gelzer-Bell R., Roth D.A., Kiel D., Insel P.A., Hammond H.K. Reduced β-adrenergic receptor activation decreases G-protein expression and β-adrenergic receptor kinase activity in porcine heart. J. Clin. Invest. 95:1995;1271-1280.
30. Pointon S.E., Banerjee S.P. α- and β-Adrenergic receptors of the rat salivary gland: elevation after chemical sympathectomy. Biochim. Biophys. Acta. 584:1979;231-241.
31. s in heterologous desensitization: a role for adenosine 3′,5′-monophosphate-dependent phosphorylation. Endocrinology. 131:1992;2774-2784.
32. Rao G.S., Seidler F.J., Slotkin T.A. Modulation of hepatic adrenergic receptor ontogeny by thyroid hormone. Res. Commun. Mol. Pathol. Pharmacol. 87:1995;27-42.
33. Seamon K., Daly J.W. Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein. J. Biol. Chem. 256:1981;9799-9801.
34. Seamon K.B., Daly J.W. Forskolin: its biological and chemical properties. Adv. Cyclic Nucleotide Protein Phosphoryl. Res. 20:1986;1-150.
35. Seidler F.J., Slotkin T.A. Presynaptic and postsynaptic contributions to ontogeny of sympathetic control of heart rate in the preweanling rat. Br. J. Pharmacol. 65:1979;431-434.
36. Shear M., Insel P.A., Melmon K.L., Coffino P. Agonist-specific refractoriness induced by isoproterenol. J. Biol. Chem. 251:1976;7572-7576.
37. Slotkin, T.A., Endocrine control of synaptic development in the sympathetic nervous system: the cardiac-sympathetic axis. In P.M. Gootman (Eds.), Developmental Neurobiology of the Autonomic Nervous System, pp. 97-133, Humana Press, Clifton, NJ, 1986.
38. Slotkin T.A., Kavlock R.J., Cowdery T., Orband L., Bartolome M., Whitmore W.L., Bartolome J. Effects of neonatal methylmercury exposure on adrenergic receptor binding sites in peripheral tissues of the developing rat. Toxicology. 41:1986;95-106.
39. Slotkin T.A., Lau C., Kavlock R.J., Whitmore W.L., Queen K.L., Orband-Miller L., Bartolome M., Baker F.E., Cameron A.M., Antolick L., Bartolome J.V. Trophic control of lung development by sympathetic neurons: effects of neonatal sympathectomy with 6-hydroxydopamine. J. Dev. Physiol. 10:1988;577-590.
40. Slotkin T.A., Levant B., Orband-Miller L., Queen K.L., Stasheff S. Do sympathetic neurons coordinate cellular development in the heart and kidney? Effects of neonatal central and peripheral catecholaminergic lesions on cardiac and renal nucleic acids and proteins. J. Pharmacol. Exp. Ther. 244:1988;166-172.
41. Slotkin T.A., Lorber B.A., McCook E.C., Barnes G.A., Seidler F.J. Neural input and the development of adrenergic intracellular signaling: neonatal denervation evokes neither receptor upregulation nor persistent supersensitivity of adenylate cyclase. Dev. Brain Res. 88:1995;17-29.
42. Slotkin T.A., Navarro H.A., McCook E.C., Seidler F.J. Fetal nicotine exposure produces postnatal up-regulation of adenylate cyclase activity in peripheral tissues. Life Sci. 47:1990;1561-1567.
43. Slotkin T.A., Seidler F.J. Adrenomedullary catecholamine release in the fetus and newborn: secretory mechanisms and their role in stress and survival. J. Dev. Physiol. 10:1988;1-16.
44. Snedecor, G.W. and Cochran, W.G., Statistical Methods, Iowa State University Press, Ames, IA, 1967.
45. Stein H.M., Oyama K., Sapien R., Chappell B.A., Padbury J.F. Prolonged β-agonist infusion does not induce desensitization or down-regulation of β-adrenergic receptors in newborn sheep. Pediatr. Res. 31:1992;462-467.
46. Stiles G.L. Mechanisms of receptor activation in adenylate cyclase. J. Cardiovasc. Pharmacol. 14:1989;S1-S5.
47. Thai L., Galluzzo J.M., McCook E.C., Seidler F.J., Slotkin T.A. Atypical regulation of hepatic adenylyl cyclase and adrenergic receptors during a critical developmental period: agonists evoke supersensitivity accompanied by failure of receptor downregulation. Pediatr. Res. 39:1996;697-707.
48. Weiss E.R., Kelleher D.J., Woon C.W., Soparkar S., Osawa S., Heasley L.E., Johnson G.L. Receptor activation of G proteins. FASEB J. 2:1988;2841-2848.
49. Whitaker-Azmitia P.M. Role of serotonin and other neurotransmitter receptors in brain development: basis for developmental pharmacology. Pharmacol. Rev. 43:1991;553-561.
50. Witkin R.M., Harden T.K. A sensitive equilibrium binding assay for soluble β-adrenergic receptors. J. Cyclic Nucleotide Res. 7:1981;235-246.
51. Yamada S., Yamamura H.I., Roeske W.R. Alterations in cardiac autonomic receptors following 6-hydroxydopamine. Mol. Pharmacol. 18:1980;185-192.
52. Yamada S., Yamamura H.I., Roeske W.R. Effects of chemical sympathectomy with 6-hydroxydopamine on α- and β-adrenoceptors and muscarinic cholinoceptors in rat kidney. Eur. J. Pharmacol. 121:1986;345-353.
53. s-catalytic unit complex of adenylate cyclase in isoproterenol-induced heterologous desensitization. Eur. J. Pharmacol. 159:1989;247-256.
54. Yanai, J., Neurobehavioral Teratology, Elsevier, Amsterdam, 1984.